Norbel Baby Co (6844) Fair Value & Analysis
Consumer Cyclical · TW · Market cap 2.3B TWD
Fair value as of: Jul 23, 2026
From 24 valuation models · updated 18 days ago
Share price −3.7% over the past month.
A solid business, but screening 23% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (58.68 TWD). The favourable scenario is already priced in.
- Solid but not exceptional quality (52/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 23, 2026.
How to read this chart
57‑month range 58.21 TWD – 201.68 TWD · fair‑value band 35.21 TWD – 58.68 TWD · the 60.70 TWD price screens above the 46.94 TWD fair value. Dashed = 300-day average. As of Jul 23, 2026.
Analysis
Norbel Baby Co (6844) currently trades at 60.70 TWD, while our model-based Fair Value estimate is 46.94 TWD, implying the stock looks roughly 22.7% overvalued today. The Quality Score stands at 52/100 (solid quality), in the Consumer Cyclical sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Norbel Baby Co generated revenue of 3.4B TWD at a net margin of 2.8%. Revenue declined 2.5% year over year. It earns a return on equity of 3.1%. The stock trades on a trailing P/E of 28.3. Fundamentals as of Jul 23, 2026
Our scenario range runs from 35.21 TWD (bear case) to 58.68 TWD (bull case); at 60.70 TWD, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 40% below its 52-week high, currently below its 200-day average. For context, the median of 10 Consumer Cyclical peers we cover trades at -24% fair-value upside, at -23%, 6844 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (81.34 TWD) versus Earnings-Based (19.51 TWD). Highest evidence: Residual Income (76).
Notify me when 6844 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 41
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Norbel Baby Co., Ltd engages in the sale of medicine, medical care, health care, maternity and baby care, and beauty care products in Taiwan. The company operates chain retail stores of cosmetics and pharmacy under the brand "Tin Tin Drugstore". It also provides consulting services. The company was founded in 1986 and is headquartered in Kaohsiung, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Norbel Baby Co reported revenue of 3.4B TWD in FY2025 versus 3.8B TWD in FY2021, a compound −2.5%/yr. Reported net income was 87.8M TWD in FY2025, compounding −24.1%/yr from FY2021.
6844 screens 23% overvalued. Compare with Casey's General Stores, Inc →
Peer Group
Specialty Retail · 220 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Specialty Retail median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Specialty Retail stocks, each showing price versus our Fair Value estimate (as of Jul 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Casey's General Stores, Inc CASY | $827.04 | $405.44 | -51% |
| Williams-Sonoma, Inc WSM | $222.84 | $164.16 | -26% |
| Ulta Beauty, Inc ULTA | $479.57 | $488.39 | +2% |
| DICK'S Sporting Goods, Inc DKS | $208.89 | $181.10 | -13% |
| Best Buy Co BBY | $83.98 | $109.12 | +30% |
| China Tourism Group 601888 | ¥52.90 | ¥40.40 | -24% |
| Tractor Supply Company TSCO | $31.01 | $35.52 | +15% |
| Murphy USA Inc MUSA | $618.57 | $423.35 | -32% |
| Five Below, Inc FIVE | $197.71 | $117.29 | -41% |
| Taiwan Mobile Co 3045 | 110.50 TWD | 80.98 TWD | -27% |
Compare Norbel Baby Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Cyclical stocks →
Frequently asked questions
Is Norbel Baby Co (6844) overvalued or undervalued?
What is the fair value of 6844?
What is the quality score of 6844?
What is the revenue of Norbel Baby Co (6844)?
What is the net profit margin of 6844?
Does Norbel Baby Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Norbel Baby Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.